FDA: Class I recall of certain Datascope/Getinge IABPs
Editor's Note
The Food and Drug Administration (FDA) on March 17 identified the recall by Datascope/Getinge of certain Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious.
The recall was initiated because the coiled cable connecting the display and base on some units may fail, causing an unexpected shutdown.
From June 2019 to August 2022, Datascope/Getinge has reported 44 complaints of damaged coiled cords resulting in unexpected shutdowns. There have been no reports of injuries or deaths.
The issue may occur in units distributed before July 24, 2017, and/or coiled cord part number 0012-00-1801. The company has developed a hardware correction to address this issue, and a service representative will contact customers to schedule installation when the correction kit is available.
Free Daily News
- Neurosurgery trial: Early evacuation improves long-term hemorrhage outcomes
- Drug shortages higher than ever
- FDA announces class 1 recalls for premixed embolic, infusion pump software
- Academic medical centers identify performance-improvement priorities
- Propofol anesthesia for colonoscopy could help find polyps, prevent cancer
- FDA Class 1 recall renews concern about historically problematic heart pumps
- New physician compensation report reveals modest pay gains but growing discontent with the profession
- Surge in corporate ownership of medical practices raises concerns over physician autonomy, care quality
- How Minneapolis healthcare real estate remained strong amid challenges, shifts in patient care preferences: Lessons for other states
- Artificial intelligence (AI) captures uncertainty in medical scans